“Anxiety is actually the most common reason, besides chronic pain, that people actually purse treatment with medical cannabis.” Image credit: YARphotography | stock.adobe.com Cannabis is a schedule 1 controlled substance, although various states allow for medical or adult use of the drug, ...
Despite being a Schedule I drug, cannabis is increasingly used in oncology for symptom management, although data remains limited. Although cannabis is a Schedule I drug, which categorizes it as having no accepted medical use, more and more states are legalizing it for recreational and/or ...
The researchers argue that more studies are urgently needed. Still, human trials have been limited because of the classification of cannabis as a Schedule 1 drug. 5. May Have Anti-Cancer Effects THC and other cannabinoids may destroy or slow the growth of certain cancer cells.16In a review pu...
Cannabis Is More Like Alcohol Than a Schedule I DrugWigmore, James G.Forensic Science Review
As long as cannabis is moved at least to Schedule 3, section280E of the tax code would no longer applyto the industry, and marijuana businesses could claim standard business tax deductions. That would provide a needed boost to profitability for many operators. ...
“The cost to bring a Schedule II drug to market is enormous, to the level that not a single company in the cannabis industry right now could afford to do so. The knowledge gap between government regulators and outside companies that would come into the industry would be enormous,...
Because cannabis is a schedule I drug in the U.S. (meaning the federal government decided it has a high potential for abuse and low potential for medical benefit), it’s difficult to study in a controlled environment. You can’t exactly give participants weed and measure how their sex habi...
our heavily restricted, bootstrapped cannabis research, the university lab in the next building over was experimenting with less restrictions on mice using other drugs: cocaine, opioids and amphetamines. (Quick note, marijuana is listed as more dangerous than cocaine, which is a Schedule II drug.)...
Still with a projected 1 billion GBP at stake, it is easy to why UK CBD manufacturers work to appease the FSA despite the regulatory hurdles. By keeping the door open, the UK has managed to keep investors interested in the CBD market and the public safe from unmonitored products. ...
In the UK cannabis currently has Schedule 1 status, the most restrictive category, which is for drugs which are not used medicinally such as LSD. “This creates a Catch 22 situation,” says Freeman. “You can’t show that cannabis and cannabis-based products have medicinal value becau...